Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2008 1
2011 1
2012 2
2013 1
2014 1
2015 1
2016 2
2017 1
2018 3
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?
McCarty CA, Fuchs MJ, Lamb A, Conway P. McCarty CA, et al. Optom Vis Sci. 2018 Mar;95(3):166-170. doi: 10.1097/OPX.0000000000001188. Optom Vis Sci. 2018. PMID: 29424826 Free PMC article.
SIGNIFICANCE: The American Academy of Ophthalmology currently recommends against routine genetic testing for complex diseases such as age-related macular degeneration (AMD). ...The study optometrist provided the patient's ri …
SIGNIFICANCE: The American Academy of Ophthalmology currently recommends against routine genetic testing for complex diseases …
Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration.
Balikova I, Postelmans L, Pasteels B, Coquelet P, Catherine J, Efendic A, Hosoda Y, Miyake M, Yamashiro K; ANGEL study group members, Thienpont B, Lambrechts D. Balikova I, et al. BMJ Open Ophthalmol. 2019 Dec 17;4(1):e000273. doi: 10.1136/bmjophth-2019-000273. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31909188 Free PMC article.
OBJECTIVE: Age-related macular degeneration (ARMD) is a leading cause of visual impairment. Intravitreal injections of anti-vascular endothelial growth factor (VEGF) are the standard treatment for wet ARMD. ...Of six SNPs tested for replication, one wa …
OBJECTIVE: Age-related macular degeneration (ARMD) is a leading cause of visual impairment. Intravitreal injecti …
Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging.
Smailhodzic D, Fleckenstein M, Theelen T, Boon CJ, van Huet RA, van de Ven JP, Den Hollander AI, Schmitz-Valckenberg S, Hoyng CB, Weber BH, Holz FG, Klevering BJ. Smailhodzic D, et al. Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8908-18. doi: 10.1167/iovs.11-7926. Invest Ophthalmol Vis Sci. 2011. PMID: 22003107 Clinical Trial.
To detect discerning features, the morphologic changes in CACD patients and in AMD patients were assessed with confocal scanning laser ophthalmoscopy (cSLO), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT). METHODS: A total o …
To detect discerning features, the morphologic changes in CACD patients and in AMD patients were assessed with confocal scanni …
An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure.
Hallam D, Collin J, Bojic S, Chichagova V, Buskin A, Xu Y, Lafage L, Otten EG, Anyfantis G, Mellough C, Przyborski S, Alharthi S, Korolchuk V, Lotery A, Saretzki G, McKibbin M, Armstrong L, Steel D, Kavanagh D, Lako M. Hallam D, et al. Stem Cells. 2017 Nov;35(11):2305-2320. doi: 10.1002/stem.2708. Epub 2017 Oct 9. Stem Cells. 2017. PMID: 28913923 Free PMC article.
Age-related macular degeneration (AMD) is the most common cause of blindness, accounting for 8.7% of all blindness globally. ...Taken together, our data indicate that the patient specific iPSC model provides a robust platform for understanding t
Age-related macular degeneration (AMD) is the most common cause of blindness, accounting for 8.7% of all blindne
[Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A, Karska-Basta I, Kobylarz J, Dziedzina S, Sanak M, Romanowska-Dixon B. Kubicka-Trząska A, et al. Klin Oczna. 2016;118(2):114-21. Klin Oczna. 2016. PMID: 29912491 Polish.
MATERIAL AND METHODS: 106 patients with age-related macular degeneration treated with intravitreal ranibizumab or bevacizumab were enrolled. ...The testing was performed using genetic probes (TaqMan Applied Biosystems) in all cases …
MATERIAL AND METHODS: 106 patients with age-related macular degeneration treated with intravitreal ranibi …
Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Wang VM, Rosen RB, Meyerle CB, Kurup SK, Ardeljan D, Agron E, Tai K, Pomykala M, Chew EY, Chan CC, Tuo J. Wang VM, et al. Mol Vis. 2012;18:2578-85. Epub 2012 Oct 20. Mol Vis. 2012. PMID: 23112570 Free PMC article.
PURPOSE: The use of anti-vascular endothelial growth factor (anti-VEGF) therapy, with drugs such as ranibizumab and bevacizumab, to treat neovascular age-related macular degeneration (nAMD) produces an effective but widely variable response. ...Pati
PURPOSE: The use of anti-vascular endothelial growth factor (anti-VEGF) therapy, with drugs such as ranibizumab and bevacizumab, to treat ne …
Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration.
Ferrara D, Seddon JM. Ferrara D, et al. JAMA Ophthalmol. 2015 Jul;133(7):785-91. doi: 10.1001/jamaophthalmol.2015.0814. JAMA Ophthalmol. 2015. PMID: 25880396 Free PMC article.
IMPORTANCE: The complement factor H R1210C rare variant confers the strongest genetic risk for age-related macular degeneration and earlier age at onset; however, its associated phenotype has not been well characterized. ...Better charact …
IMPORTANCE: The complement factor H R1210C rare variant confers the strongest genetic risk for age-related macular
Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
Teper SJ, Nowinska A, Pilat J, Wylegala E. Teper SJ, et al. Photodiagnosis Photodyn Ther. 2016 Mar;13:108-113. doi: 10.1016/j.pdpdt.2016.01.006. Epub 2016 Jan 15. Photodiagnosis Photodyn Ther. 2016. PMID: 26780119 Clinical Trial.
BACKGROUND: Treatment of neovascular age-related macular degeneration (nAMD) remains a major challenge in ophthalmology. It is essential to determine which of VEGF inhibition non-responders can benefit from photodynamic therapy (PDT). ...CONCLUS …
BACKGROUND: Treatment of neovascular age-related macular degeneration (nAMD) remains a major challenge in ophtha …
Clinical characteristics of familial and sporadic age-related macular degeneration: differences and similarities.
Saksens NT, Kersten E, Groenewoud JM, van Grinsven MJ, van de Ven JP, Sánchez CI, Schick T, Fauser S, den Hollander AI, Hoyng CB, Boon CJ. Saksens NT, et al. Invest Ophthalmol Vis Sci. 2014 Oct 9;55(11):7085-92. doi: 10.1167/iovs.14-14659. Invest Ophthalmol Vis Sci. 2014. PMID: 25301878 Clinical Trial.
PURPOSE: We describe the differences and similarities in clinical characteristics and phenotype of familial and sporadic patients with age-related macular degeneration (AMD). METHODS: We evaluated data of 1828 AMD patients and 1715 contro …
PURPOSE: We describe the differences and similarities in clinical characteristics and phenotype of familial and sporadic patients wit …
Multimodal imaging in a pedigree of X-linked Retinoschisis with a novel RS1 variant.
Stephenson K, Dockery A, Wynne N, Carrigan M, Kenna P, Jane Farrar G, Keegan D. Stephenson K, et al. BMC Med Genet. 2018 Nov 12;19(1):195. doi: 10.1186/s12881-018-0712-8. BMC Med Genet. 2018. PMID: 30419843 Free PMC article.
METHODS: The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients
METHODS: The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examinati …
16 results
Jump to page
Feedback